--- title: "UnitedHealth Group (NYSE:UNH) Price Target Cut to $325.00 by Analysts at Morgan Stanley" description: "Morgan Stanley has reduced its price target for UnitedHealth Group (NYSE:UNH) from $342.00 to $325.00 while maintaining an \"overweight\" rating. This new target suggests an 8.85% upside from the stock'" type: "news" locale: "en" url: "https://longbridge.com/en/news/254029723.md" published_at: "2025-08-21T15:29:56.000Z" --- # UnitedHealth Group (NYSE:UNH) Price Target Cut to $325.00 by Analysts at Morgan Stanley > Morgan Stanley has reduced its price target for UnitedHealth Group (NYSE:UNH) from $342.00 to $325.00 while maintaining an "overweight" rating. This new target suggests an 8.85% upside from the stock's previous close. Other analysts have also adjusted their ratings, with some downgrading the stock. Currently, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $365.38. The stock recently traded at $298.59, with a market cap of $270.42 billion and a P/E ratio of 12.95. UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target cut by stock analysts at Morgan Stanley from $342.00 to $325.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the healthcare conglomerate's stock. Morgan Stanley's target price would indicate a potential upside of 8.85% from the stock's previous close. - Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH Other equities research analysts also recently issued reports about the stock. Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. KeyCorp lowered their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Finally, TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $365.38. Get **UnitedHealth Group** alerts: **Get Our Latest Analysis on UnitedHealth Group** ## UnitedHealth Group Price Performance - Can HCA Healthcare Revive the Market’s Weakest Sector? NYSE:UNH traded down $5.6520 on Wednesday, reaching $298.5880. The stock had a trading volume of 7,282,663 shares, compared to its average volume of 12,787,148. The company has a market capitalization of $270.42 billion, a P/E ratio of 12.95, a price-to-earnings-growth ratio of 1.99 and a beta of 0.43. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day moving average price of $289.03 and a 200-day moving average price of $393.55. UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the firm posted $6.80 earnings per share. The company's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group will post 29.54 EPS for the current year. ## Insider Buying and Selling - Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.28% of the stock is currently owned by corporate insiders. ## Institutional Trading of UnitedHealth Group A number of hedge funds have recently modified their holdings of the stock. Financial Management Professionals Inc. lifted its holdings in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares in the last quarter. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.0% in the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after buying an additional 21 shares in the last quarter. Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after buying an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group lifted its holdings in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock. ## UnitedHealth Group Company Profile (Get Free Report) UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. ## See Also - Five stocks we like better than UnitedHealth Group - How to Buy Cheap Stocks Step by Step - Who Won and Who Lost in Nuclear Energy’s Q2 Earnings - Insider Trades May Not Tell You What You Think - 2 Powerful Forces Now Back Intel's Turnaround - How Can Investors Benefit From After-Hours Trading - Archer's Flight Milestones & Defense Wins Excite Wall Street *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in UnitedHealth Group Right Now? Before you consider UnitedHealth Group, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list. While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [UNH.US - Unitedhealth](https://longbridge.com/en/quote/UNH.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 联合健康｜8-K：2025 财年营收 4476 亿美元不及预期 | | [Link](https://longbridge.com/en/news/273832348.md) | | DELL, SPOT, UNH：全球最大的对冲基金正在市场中寻找抄底机会 | 桥水基金（Bridgewater Associates），全球最大的对冲基金，管理资产达 1360 亿美元，在 2025 年第四季度对表现不佳的股票进行了重大投资，包括戴尔（DELL）、Spotify（SPOT）和联合健康（UnitedHe | [Link](https://longbridge.com/en/news/276384705.md) | | 沃尔玛四季度财报超预期但盈利指引不及预期，CEO 称 “美国低收入家庭只能勉强维持生计” | 沃尔玛 Q4 营收超预期，新财年盈利指引（每股 2.75-2.85 美元）远低于市场预期的 2.96 美元，显示通胀压力下消费者支出不确定性犹存，拖累股价下跌 1.38%。财报印证 K 型” 分化：高收入家庭驱动增长，低收入群体 “钱包吃紧 | [Link](https://longbridge.com/en/news/276398633.md) | | 谷歌突然发布 Gemini 3.1 Pro：核心推理性能直接翻倍 | 谷歌发布了最新的大模型 Gemini 3.1 Pro，其推理性能较去年发布的 Gemini 3 Pro 翻倍。在 ARC-AGI-2 评测中，Gemini 3.1 Pro 得分 77.1%，显示出强大的推理能力。新模型支持多源数据综合和复杂 | [Link](https://longbridge.com/en/news/276396515.md) | | 学习英伟达刺激芯片销售，AMD 为 “AI 云” 借款做担保 | AMD 为扩大市场份额祭出金融 “狠招”！为初创公司 Crusoe 的 3 亿美元购芯贷款提供担保，承诺在其无客户时 “兜底” 租用芯片。这一复刻英伟达 “租卡云” 路径的策略虽能短期推高销量，但也令 AMD 在 AI 需求放缓时面临更大的 | [Link](https://longbridge.com/en/news/276401504.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.